Evidence has shown that elevated cTn is associated with mortality in patients with AIS in the long or short term.11 12 However, the distribution of hs-cTnI elevation or hs-cTnI dynamic changes in patients who underwent MT and its role in the 90-day mortality is unclear and is rarely investigated. The gene discussed is TNNI3; the disease is androgen insensitivity syndrome.